3

OWNERSHIP DOCUMENT

Company: Eledon Pharmaceuticals, Inc.
Filed: October 5, 2020
Period of Report: October 1, 2020
Accession Number: 0000921895-20-002529

View Document ↗ View on SEC.gov ↗